Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Plos One|July 23, 2013
IL-10 conditioning of human skin affects the distribution of migratory dendritic cell subsets and functional T cell differentiationJelle J Lindenberg, Dinja Oosterhoff, Claudia C Sombroek, et al.
Cancer Research|January 15, 2016
Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB TrialLale Erdem-Eraslan, Martin J van den Bent, Youri Hoogstrate, et al.
Head & Neck|August 11, 2016
Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adultsEline Boon, Winette T A van der Graaf, Hans Gelderblom, et al.
The Oncologist|December 18, 2023
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery ProtocolIlse A C Spiekman, Birgit S Geurts, Laurien J Zeverijn, et al.
Lancet (London, England)|November 20, 2018
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trialHisham Mehanna, Max Robinson, Andrew Hartley, et al.
The Lancet. Oncology|July 19, 2014
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trialWalter Taal, Hendrika M Oosterkamp, Annemiek M E Walenkamp, et al.
Neuro-Oncology|October 5, 2021
The EGFRvIII transcriptome in glioblastoma: A meta-omics analysisYouri Hoogstrate, Santoesha A Ghisai, Maurice de Wit, et al.
Pageof 4